Lower Drug Costs for Families Act
HR 2554, the Lower Drug Costs for Families Act, modifies how Medicare calculates rebates for prescription drugs under Parts B and D. It changes the base year for rebate calculations from 2021 to 2016, which would increase rebates to Medicare by accounting for higher drug price growth since 2016. The bill also adjusts how "commercial market" drug units are counted for rebates, excluding units paid for through Medicaid or other programs. These changes apply to Medicare Part B drugs starting in 2026 and Part D drugs starting in 2025, directly affecting drug manufacturers and Medicare's rebate payments.
Bill status
in committee
1 of 4 stages cleared
Introduction
Apr 2025
Committee Review
Floor Vote
President
Introduced Apr 1, 2025
Last action Apr 1, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
1
Apr 1, 2025
Committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Apr 1, 2025
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Steven Horsford
DDemocratic
Co
Henry C. "Hank" Johnson, Jr.
DDemocratic
Co
Sheila Cherfilus-McCormick
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HR 2554
Scope: US
Hi! I can help you understand HR 2554. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline